Key Metrics
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.91
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Immunology
- Q1 Immunology and Allergy
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Immunotherapy
- Lung cancer
- Overall survival
- Melanoma
- Electroporation
- Antigen
- Tumor growth
- Progression-free survival
- Plasma levels
- Leiomyosarcoma
- Myeloid cells
- Immunization
- Tumor microenvironment
- Breast cancer
- Disease progression
- Antitumor immunity
- Tumor-infiltrating lymphocytes
- Lymph node
- Immune checkpoint
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | GBP 2495 |
| Publication Time | 24 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 24 |
| Article Processing Charges | GBP 2495 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in ONCOIMMUNOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperScite analysis
Powered by scite_
3.6k articles received 97.5k citations see all
- 3,660 Supporting
- 92,739 Mentioning
- 386 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 20 Corrections
- 18 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
21%
4 to 6 months
57%
7 to 9 months
16%
Above 9 months
6%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has ONCOIMMUNOLOGY been actively publishing?
ONCOIMMUNOLOGY has been in operation since 2012 till date.
What is the publishing frequency of ONCOIMMUNOLOGY ?
ONCOIMMUNOLOGY published with a Monthly frequency.
What is the eISSN & pISSN for ONCOIMMUNOLOGY ?
For ONCOIMMUNOLOGY,eISSN is 2162-402X and pISSN is2162-402X.
What is the SJR for ONCOIMMUNOLOGY ?
SJR for ONCOIMMUNOLOGY is Q1.
Who is the publisher of ONCOIMMUNOLOGY ?
TAYLOR & FRANCIS INC is the publisher of ONCOIMMUNOLOGY.